股號 / 名稱 | 營收 | 稅後淨利 |
URGN Urogen Pharma Ltd | 18,781,000.0 | -32,286,000.0 |
AKYA Akoya Biosciences Inc | 18,350,000.0 | -23,484,000.0 |
ADCT ADC Therapeutics SA | 18,053,000.0 | -45,919,000.0 |
DTIL Precision BioSciences Inc | 17,584,000.0 | 8,588,000.0 |
CDXS Codexis Inc | 17,073,000.0 | -11,505,000.0 |
TELA TELA Bio Inc | 16,603,000.0 | -5,661,000.0 |
NRIX Nurix Therapeutics Inc | 16,585,000.0 | -41,518,000.0 |
THTX Theratechnologies Inc | 16,247,000.0 | -4,481,000.0 |
ALEC Alector Inc | 15,893,000.0 | -36,079,000.0 |
RGNX Regenxbio Inc | 15,622,000.0 | -63,330,000.0 |
GTHX G1 Therapeutics Inc | 14,476,000.0 | -10,219,000.0 |
ARQT Arcutis Biotherapeutics Inc | 13,526,000.0 | -66,284,000.0 |
STRO Sutro Biopharma Inc | 13,008,000.0 | -58,213,000.0 |
WVE WAVE Life Sciences Ltd | 12,538,000.0 | -31,558,000.0 |
TSVT 2Seventy Bio Inc | 12,435,000.0 | -52,673,000.0 |
EYPT EyePoint Pharmaceuticals Inc | 11,684,000.0 | -29,284,000.0 |
MXCT MaxCyte Inc | 11,342,000.0 | -9,526,000.0 |
MGNX MacroGenics Inc | 10,720,000.0 | -46,073,000.0 |
EQ Equillium Inc | 10,689,000.0 | -2,734,000.0 |
BFRI Biofrontera Inc | 10,596,000.0 | 3,526,000.0 |
KYMR Kymera Therapeutics Inc | 10,287,000.0 | -48,557,000.0 |
ZYME Zymeworks Inc | 10,030,000.0 | -31,653,000.0 |
ABCL Abcellera Biologics Inc | 9,954,000.0 | -40,610,000.0 |
MRSN Mersana Therapeutics Inc | 9,245,000.0 | -19,306,000.0 |
DBVT Dbv Technologies SA | 8,875,000.0 | -11,186,000.0 |
BNGO Bionano Genomics Inc | 8,769,000.0 | -31,422,000.0 |
ENZ Enzo Biochem Inc | 8,553,000.0 | -863,000.0 |
QURE Uniqure NV | 8,485,000.0 | -65,618,000.0 |
CDTX Cidara Therapeutics Inc | 8,463,000.0 | -10,326,000.0 |
ETON Eton Pharmaceuticals Inc | 7,966,000.0 | -811,000.0 |
MRUS Merus NV | 7,889,000.0 | -34,456,000.0 |
TKNO Alpha Teknova Inc | 7,867,000.0 | -10,656,000.0 |
SBFM Sunshine Biopharma Inc | 7,680,200.0 | -1,250,020.0 |
BEAM Beam Therapeutics Inc | 7,410,000.0 | -98,669,000.0 |
ANAB AnaptysBio Inc | 7,179,000.0 | -43,936,000.0 |
TNGX Tango Therapeutics Inc | 6,471,000.0 | -37,914,000.0 |
SCPH scPharmaceuticals Inc | 6,096,000.0 | -13,812,000.0 |
OCGN Ocugen Inc | 6,036,000.0 | -9,493,000.0 |
PULM Pulmatrix Inc | 5,885,000.0 | 825,000.0 |
ADAP Adaptimmune Therapeutics PLC | 5,678,000.0 | -48,503,000.0 |
AADI Aadi Bioscience Inc | 5,353,000.0 | -18,289,000.0 |
BOLT Bolt Biotherapeutics Inc | 5,274,000.0 | -10,811,000.0 |
CAPR Capricor Therapeutics Inc | 4,906,880.0 | -9,794,070.0 |
STOK Stoke Therapeutics Inc | 4,216,000.0 | -26,374,000.0 |
IMNM Immunome Inc | 3,826,000.0 | -92,634,000.0 |
RNA Avidity Biosciences Inc | 3,543,000.0 | -68,855,000.0 |
MESO Mesoblast Ltd | 3,388,000.0 | -32,539,000.0 |
SEER Seer Inc | 3,066,000.0 | -20,679,000.0 |
TCON TRACON Pharmaceuticals Inc | 3,045,000.0 | 439,000.0 |
CCCC C4 Therapeutics Inc | 3,039,000.0 | -28,361,000.0 |
LQDA Liquidia Corp | 2,972,000.0 | -40,928,000.0 |
KRON Kronos Bio Inc | 2,520,000.0 | -29,958,000.0 |
CRBU Caribou Biosciences Inc | 2,429,000.0 | -41,234,000.0 |
THMO Thermogenesis Holdings Inc | 2,406,000.0 | -7,599,000.0 |
OMGA Omega Therapeutics Inc | 2,360,000.0 | -20,129,000.0 |
CARA Cara Therapeutics Inc | 2,135,000.0 | -30,696,000.0 |
CRIS Curis Inc | 2,086,000.0 | -11,876,000.0 |
SPRB Spruce Biosciences Inc | 2,002,000.0 | -11,625,000.0 |
FATE Fate Therapeutics Inc | 1,925,000.0 | -48,004,000.0 |
PHAT Phathom Pharmaceuticals Inc | 1,912,000.0 | -82,852,000.0 |
DARE Dare Bioscience Inc | 1,807,890.0 | -5,057,560.0 |
GRTS Gritstone bio Inc | 1,742,000.0 | -40,385,000.0 |
CUE Cue Biopharma Inc | 1,717,000.0 | -12,347,000.0 |
OCUP Ocuphire Pharma Inc | 1,711,000.0 | -7,106,000.0 |
ABUS Arbutus Biopharma Corp | 1,532,000.0 | -17,875,000.0 |
XOMA XOMA Corp | 1,490,000.0 | -8,595,000.0 |
INVO INVO Bioscience Inc | 1,381,750.0 | -1,994,780.0 |
HCWB HCW Biologics Inc | 1,324,000.0 | -10,680,530.0 |
PIRS Pieris Pharmaceuticals Inc | 1,299,000.0 | -4,584,000.0 |
JANX Janux Therapeutics Inc | 1,252,000.0 | -14,760,000.0 |
PGEN Precigen Inc | 1,228,000.0 | -33,056,000.0 |
EDIT Editas Medicine Inc | 1,135,000.0 | -61,950,000.0 |
LXRX Lexicon Pharmaceuticals Inc | 1,130,000.0 | -48,397,000.0 |
STTK Shattuck Labs Inc | 1,115,000.0 | -18,504,000.0 |
GLUE Monte Rosa Therapeutics Inc | 1,064,000.0 | -31,968,000.0 |
VTVT vTv Therapeutics Inc | 1,000,000.0 | -6,019,000.0 |
ALGS Aligos Therapeutics Inc | 986,000.0 | -34,863,000.0 |
VBIV VBI Vaccines Inc | 853,000.0 | -13,000.0 |
CYTK Cytokinetics Inc | 835,000.0 | -135,643,000.0 |
ADAG Adagene Inc | 815,750.0 | -14,837,560.0 |
HOWL Werewolf Therapeutics Inc | 742,000.0 | -16,193,000.0 |
IOVA Iovance Biotherapeutics Inc | 715,000.0 | -112,976,000.0 |
MGTX MeiraGTx Holdings PLC | 697,000.0 | -20,442,000.0 |
SEEL Seelos Therapeutics Inc | 653,000.0 | -5,453,000.0 |
BTAI BioXcel Therapeutics Inc | 582,000.0 | -26,791,000.0 |
EVGN Evogene Ltd | 578,000.0 | -7,337,000.0 |
TCRX TScan Therapeutics Inc | 566,000.0 | -30,142,000.0 |
AQB AquaBounty Technologies Inc | 553,250.0 | -8,424,970.0 |
ENSC Ensysce Biosciences Inc | 515,030.0 | -3,504,360.0 |
CRSP CRISPR Therapeutics AG | 504,000.0 | -116,591,000.0 |
IGMS IGM Biosciences Inc | 497,000.0 | -49,816,000.0 |
SGMO Sangamo Therapeutics Inc | 481,000.0 | -49,089,000.0 |
PRAX Praxis Precision Medicines Inc | 431,000.0 | -39,553,000.0 |
VTGN Vistagen Therapeutics Inc | 411,400.0 | -6,349,800.0 |
XAIR Beyond Air Inc | 391,000.0 | -17,257,000.0 |
APRE Aprea Therapeutics Inc | 380,570.0 | -2,810,090.0 |
LVTX LAVA Therapeutics NV | 353,000.0 | -6,498,000.0 |
ABSI Absci Corp | 338,000.0 | -23,545,000.0 |
DYAI Dyadic International Inc | 334,620.0 | -2,009,600.0 |
CYTH Cyclo Therapeutics Inc | 311,400.0 | -5,642,410.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股營收排名、龍頭是誰?
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例